as 11-15-2024 4:00pm EST
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
Founded: | 1996 | Country: | United States |
Employees: | N/A | City: | GERMANTOWN |
Market Cap: | 167.8M | IPO Year: | N/A |
Target Price: | $2.00 | AVG Volume (30 days): | 4.7M |
Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.13 | EPS Growth: | N/A |
52 Week Low/High: | $0.28 - $0.75 | Next Earning Date: | 11-07-2024 |
Revenue: | $22,205,000 | Revenue Growth: | 11.41% |
Revenue Growth (this year): | 1.05% | Revenue Growth (next year): | 61.23% |
SENS Breaking Stock News: Dive into SENS Ticker-Specific Updates for Smart Investing
GlobeNewswire
5 days ago
GuruFocus.com
9 days ago
Zacks
10 days ago
Associated Press Finance
10 days ago
GlobeNewswire
10 days ago
GuruFocus.com
11 days ago
MT Newswires
23 days ago
GlobeNewswire
23 days ago
The information presented on this page, "SENS Senseonics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.